Literature DB >> 10797403

Dystrophin mutations predict cellular susceptibility to oxidative stress.

M H Disatnik1, J S Chamberlain, T A Rando.   

Abstract

Mutations in the dystrophin gene that lead to the expression of truncated forms of the dystrophin protein cause muscular dystrophies of varying severities both in humans and in mice. We have shown previously that dystrophin-deficient muscle is more susceptible to oxidative injury than is normal muscle. In this report, we have used muscle cells derived from mdx mice, which express no dystrophin, and mdx-transgenic strains that express full-length dystrophin or truncated forms of dystrophin to explore further the relationship between dystrophin expression and susceptibility of muscle to oxidative injury. We show that, when differentiated into myotubes, the relative susceptibility of the cell populations to oxidative stress correlates with the severity of the dystrophy in the strain from which the cells were isolated. The most susceptible populations exhibited the greatest oxidative damage as assessed by protein oxidation. Thus, the relative efficacy of truncated dystrophin proteins to protect muscle from necrotic degeneration in vivo is predicted by their ability to protect muscle cells from free radical mediated injury. These findings support the hypothesis that the dystrophin protein complex may have important regulatory or signaling properties in terms of cell survival and antioxidant defense mechanisms. Copyright 2000 John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10797403     DOI: 10.1002/(sici)1097-4598(200005)23:5<784::aid-mus17>3.0.co;2-y

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  15 in total

1.  Sarcolemmal damage in dystrophin deficiency is modulated by synergistic interactions between mechanical and oxidative/nitrosative stresses.

Authors:  Roy W R Dudley; Gawiyou Danialou; Karuthapillai Govindaraju; Larry Lands; David E Eidelman; Basil J Petrof
Journal:  Am J Pathol       Date:  2006-04       Impact factor: 4.307

Review 2.  Nutrition strategies to improve physical capabilities in Duchenne muscular dystrophy.

Authors:  J Davoodi; C D Markert; K A Voelker; S M Hutson; Robert W Grange
Journal:  Phys Med Rehabil Clin N Am       Date:  2011-12-13       Impact factor: 1.784

Review 3.  Redox Control of Skeletal Muscle Regeneration.

Authors:  Emmeran Le Moal; Vincent Pialoux; Gaëtan Juban; Carole Groussard; Hassane Zouhal; Bénédicte Chazaud; Rémi Mounier
Journal:  Antioxid Redox Signal       Date:  2017-02-06       Impact factor: 8.401

4.  Reducing sarcolipin expression improves muscle metabolism in mdx mice.

Authors:  Rekha Balakrishnan; Satvik Mareedu; Gopal J Babu
Journal:  Am J Physiol Cell Physiol       Date:  2022-01-05       Impact factor: 4.249

5.  Early onset of lipofuscin accumulation in dystrophin-deficient skeletal muscles of DMD patients and mdx mice.

Authors:  Yoshiko Nakae; Peter J Stoward; Tatsuo Kashiyama; Masayuki Shono; Akiko Akagi; Tetsuya Matsuzaki; Ikuya Nonaka
Journal:  J Mol Histol       Date:  2004-06       Impact factor: 2.611

6.  The Dietary Supplement Protandim Decreases Plasma Osteopontin and Improves Markers of Oxidative Stress in Muscular Dystrophy Mdx Mice.

Authors:  Muhammad Muddasir Qureshi; Warren C McClure; Nicole L Arevalo; Rick E Rabon; Benjamin Mohr; Swapan K Bose; Joe M McCord; Brian S Tseng
Journal:  J Diet Suppl       Date:  2010-06-01

7.  Muscular dystrophy therapy by nonautologous mesenchymal stem cells: muscle regeneration without immunosuppression and inflammation.

Authors:  Arsalan Shabbir; David Zisa; Merced Leiker; Curtis Johnston; Huey Lin; Techung Lee
Journal:  Transplantation       Date:  2009-05-15       Impact factor: 4.939

Review 8.  Contribution of oxidative stress to pathology in diaphragm and limb muscles with Duchenne muscular dystrophy.

Authors:  Jong-Hee Kim; Hyo-Bum Kwak; LaDora V Thompson; John M Lawler
Journal:  J Muscle Res Cell Motil       Date:  2012-10-28       Impact factor: 2.698

9.  Subcutaneous injection, from birth, of epigallocatechin-3-gallate, a component of green tea, limits the onset of muscular dystrophy in mdx mice: a quantitative histological, immunohistochemical and electrophysiological study.

Authors:  Yoshiko Nakae; Katsuya Hirasaka; Junpei Goto; Takeshi Nikawa; Masayuki Shono; Mizuko Yoshida; Peter J Stoward
Journal:  Histochem Cell Biol       Date:  2008-02-09       Impact factor: 4.304

10.  Therapeutic effects of the superoxide dismutase mimetic compound MnIIMe2DO2A on experimental articular pain in rats.

Authors:  Lorenzo Di Cesare Mannelli; Daniele Bani; Andrea Bencini; Maria Luisa Brandi; Laura Calosi; Miriam Cantore; Anna Maria Carossino; Carla Ghelardini; Barbara Valtancoli; Paola Failli
Journal:  Mediators Inflamm       Date:  2013-06-06       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.